Healthcare provider profile · identity verified

Patrick Y. Kan, MD

Family Practice · CLOVIS, CA · NPI 1538247036

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	720	248
Amlodipine Besylate	Amlodipine Besylate	499	181
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	497	107
Levothyroxine Sodium	Levothyroxine Sodium	452	147
Losartan Potassium	Losartan Potassium	405	138
Lisinopril	Lisinopril	370	127
Pantoprazole Sodium	Pantoprazole Sodium	318	125
Albuterol Sulfate Hfa	Albuterol Sulfate	311	141
Tamsulosin Hcl	Tamsulosin Hcl	310	115
Gabapentin	Gabapentin	261	94
Tramadol Hcl	Tramadol Hcl	247	65
Metoprolol Tartrate	Metoprolol Tartrate	228	71
Atenolol	Atenolol	215	72
Meloxicam	Meloxicam	210	116
Doxycycline Monohydrate	Doxycycline Monohydrate	209	167
Trazodone Hcl	Trazodone Hcl	205	69
Fluticasone Propionate	Fluticasone Propionate	192	94
Famotidine	Famotidine	181	68
Metformin Hcl Er	Metformin Hcl	177	66
Tizanidine Hcl	Tizanidine Hcl	174	69
Furosemide	Furosemide	170	76
Jardiance	Empagliflozin	164	53
Glipizide	Glipizide	158	58
Ozempic	Semaglutide	150	28
Omeprazole	Omeprazole	130	52
Triamcinolone Acetonide	Triamcinolone Acetonide	130	68
Duloxetine Hcl	Duloxetine Hcl	127	51
Prednisone	Prednisone	127	85
Alprazolam	Alprazolam	122	24
Ibuprofen	Ibuprofen	115	49
Metformin Hcl	Metformin Hcl	114	40
Pregabalin	Pregabalin	111	23
Hydrochlorothiazide	Hydrochlorothiazide	110	40
Metoprolol Succinate	Metoprolol Succinate	107	46
Rosuvastatin Calcium	Rosuvastatin Calcium	107	40
Hydralazine Hcl	Hydralazine Hcl	104	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	103	41
Potassium Chloride	Potassium Chloride	100	39
Allopurinol	Allopurinol	96	30
Celecoxib	Celecoxib	96	24
Cephalexin	Cephalexin	94	76
Mupirocin	Mupirocin	93	62
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	93	45
Simvastatin	Simvastatin	92	39
Lactulose	Lactulose	85	43
Breyna	Budesonide/Formoterol Fumarate	84	36
Amoxicillin	Amoxicillin	81	47
Montelukast Sodium	Montelukast Sodium	80	28
Ondansetron Odt	Ondansetron	79	36
Clopidogrel	Clopidogrel Bisulfate	78	31
Mirtazapine	Mirtazapine	78	26
Alvesco	Ciclesonide	76	35
Sertraline Hcl	Sertraline Hcl	76	28
Ofloxacin	Ofloxacin	74	50
Carvedilol	Carvedilol	73	28
Colchicine	Colchicine	72	36
Calcitonin-Salmon	Calcitonin,salmon,synthetic	68	16
Donepezil Hcl	Donepezil Hcl	68	22
Ipratropium Bromide	Ipratropium Bromide	68	31
Bumetanide	Bumetanide	66	27
Trospium Chloride	Trospium Chloride	66	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	63	25
Lorazepam	Lorazepam	63	29
Acetaminophen-Codeine	Acetaminophen With Codeine	62	20
Ezetimibe	Ezetimibe	62	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	61	55
Hydroxyzine Hcl	Hydroxyzine Hcl	60	20
Baclofen	Baclofen	59	16
Escitalopram Oxalate	Escitalopram Oxalate	58	17
Lovastatin	Lovastatin	58	21
Temazepam	Temazepam	58	suppressed
Terazosin Hcl	Terazosin Hcl	54	17
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	52	11
Humulin N	Insulin Nph Human Isophane	49	14
Spiriva Respimat	Tiotropium Bromide	49	15
Finasteride	Finasteride	48	18
Pravastatin Sodium	Pravastatin Sodium	48	15
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	47	16
Prochlorperazine Maleate	Prochlorperazine Maleate	47	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	18
Alendronate Sodium	Alendronate Sodium	45	17
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	43	17
Azithromycin	Azithromycin	42	35
Methocarbamol	Methocarbamol	41	suppressed
Oxycodone Hcl	Oxycodone Hcl	41	11
Citalopram Hbr	Citalopram Hydrobromide	40	17
Fluoxetine Hcl	Fluoxetine Hcl	40	13
Nifedipine Er	Nifedipine	40	15
Primidone	Primidone	39	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	38	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	36
Pradaxa	Dabigatran Etexilate Mesylate	36	13
Nitroglycerin	Nitroglycerin	35	24
Clonidine Hcl	Clonidine Hcl	33	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	33	suppressed
Spironolactone	Spironolactone	33	14
Wixela Inhub	Fluticasone Propion/Salmeterol	33	13
Propranolol Hcl	Propranolol Hcl	32	11
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Morphine Sulfate Er	Morphine Sulfate	31	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	30	30
Acyclovir	Acyclovir	29	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	24
Dicyclomine Hcl	Dicyclomine Hcl	28	16
Flecainide Acetate	Flecainide Acetate	28	suppressed
Cefadroxil	Cefadroxil	27	23
Clindamycin Phosphate	Clindamycin Phosphate	27	16
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Megestrol Acetate	Megestrol Acetate	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	16
Clobetasol Propionate	Clobetasol Propionate	26	13
Nabumetone	Nabumetone	26	12
Fluocinonide	Fluocinonide	25	19
Hydrocortisone	Hydrocortisone	25	18
Cholestyramine	Cholestyramine (With Sugar)	24	suppressed
Clonazepam	Clonazepam	24	suppressed
Terbinafine Hcl	Terbinafine Hcl	24	15
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Alclometasone Dipropionate	Alclometasone Dipropionate	19	13
Digoxin	Digoxin	19	suppressed
Fluconazole	Fluconazole	19	suppressed
Rizatriptan	Rizatriptan Benzoate	19	suppressed
Lidocaine	Lidocaine	18	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Humulin R	Insulin Regular, Human	16	suppressed
Levofloxacin	Levofloxacin	16	14
Naproxen	Naproxen	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Eliquis	Apixaban	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	14	suppressed
Epinephrine	Epinephrine	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	13	11
Nystatin	Nystatin	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	13
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Estradiol	Estradiol	11	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Naloxone Hcl	Naloxone Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error